Back to Journals » Vascular Health and Risk Management » Volume 12

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab

Total article views   Abstract views HTML views PDF downloads Totals
34,895 Dovepress* 6,477 2,663+ 2,345 9,140
PubMed Central* 0 25,755 4,952 25,755
Totals 6,477 28,418 7,297 34,895
*Since 17 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
38 0 0 0 18 20

View citations on PubMed Central and Google Scholar